Description

Octaplas LG A (II) solution for infusions 45-70 mg. 200 ml

Ingredients

Octaplas LG A (II) solution for infusions 45-70 mg. 200 ml contains a balanced combination of plasma proteins, including albumin, immunoglobulins, clotting factors, and other essential components.

Dosage

The recommended dosage of Octaplas LG A (II) solution for infusions is determined by the patient’s weight, medical condition, and the intended therapeutic goal. It is administered intravenously under the supervision of a healthcare professional.

Indications

Octaplas LG A (II) solution for infusions is indicated for the treatment of various medical conditions that require replacement of specific plasma proteins, such as in patients with coagulation disorders, immunodeficiencies, or severe burns.

Contraindications

This product is contraindicated in individuals with a history of hypersensitivity to plasma-derived products or any of the components in the formulation. It should not be used in patients with selective IgA deficiency.

Directions

The administration of Octaplas LG A (II) solution for infusions should be done according to the healthcare provider’s instructions. The infusion rate and duration may vary based on the patient’s condition and response to treatment.

Scientific Evidence

Studies have shown that Octaplas LG A (II) solution for infusions is effective in restoring and maintaining adequate levels of plasma proteins in patients with various medical conditions. Research has demonstrated its safety and efficacy in clinical settings.

Pharmacologically, Octaplas LG A (II) solution interacts with the body by providing essential plasma proteins that are crucial for normal physiological functions. These proteins play a vital role in coagulation, immunity, and other biological processes.

Compared to similar products, Octaplas LG A (II) solution offers a well-balanced composition of plasma proteins, ensuring comprehensive therapeutic benefits for patients in need of plasma protein replacement therapy.